General provisions

This course replaces and corresponds to the course 3FB115 Pharmacotherapy. 1.5 credits (hp) correspond to 1 credit point (p) according to previous study regulation.

Entry requirements

For applicants on - the Master of Science Programme in Pharmacy 100 credit points/150 credits from term 1 to 6 is required and that the student has followed all earlier courses within the programme. - the Bachelor of Science Programme in Pharmacy 40 credit points/60 credits from term 1 to 3 is required and that the student has followed all earlier courses within the programme.

Learning outcomes

The student should on completion of the course independently be able to assess and evaluate a pharmacotherapy from the patient's individual prerequisites and the specific properties of the drugs. After examination, the student should be able to: - describe the most common symptoms for included diseases (according to current course description) and identify a disease from given symptom - state which basic laboratory tests and other investigations that are of value to diagnosis and monitoring of drug treatment - choose and justify appropriate drug to given patient with regard to current recommendations and patient-related factors such as other diseases, age, organ functions and other drug treatment - choose and justify appropriate dose, dosage intervals and pharmaceutical form to given patient with regard to age, organ functions and the pharmacokinetics, pharmacodynamics and toxicity of the drug - calculate creatinine clearance by means of Cockroft-Gaults equation and apply this when assessing kidney function - explain generally dissents in basic laboratory values and see possible connections to drug treatment - discover, evaluate and possibly take care of side effects and interactions on the basis of medical history laboratory values, symptoms and drug treatment - choose and justify appropriate non-pharmacological treatment to given patient with regard to current recommendations

Content

The course includes common diseases within primary care and in patient care, Swedish therapeutic recommendations, drug choices, dosage choices, individual variability and side effects. Work with interactions takes place in the form of a workshop. The student works with and discusses lifelike patient cases in the form of summarising descriptions where medical history, symptoms and laboratory values are stated. During the course, the student may also train: - the ability to search, sort, critically review and pass on drug-related information - oral presentation in groups - decision making - independent thinking - work in groups

Instruction

Problem-based learning is used as educational method. Lectures, group exercise, seminars, workshop and individual studies of literature are included. Compulsory parts of the course: Course introduction, group meetings, seminars and exam follow-up

Assessment

Examination takes place at the end of the course. For a passing grade the student must pass the examination (examination code), and all portions of the course that are obligatory (examination code). Obligatory portions of the course may be completed or re-taken when the same course is offered again, if and only it, the course is not full. Students who have failed the first examination are allowed five re-examinations.